The expression levels of endothelin-1 and nuclear factor-κB in the lung tissue of acute pulmonary embolism and the effects of thrombolysis and dexamethasone

Zhonghua Jiehe he Huxi Zazhi

Volumn 28, Issue 9, 2005, Pages 604-607

  Zhang, Dou Xia ^a   Zhang, Ling ^a   Bai, Ming ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Ant inflammation; Endothelin 1; NF kappa B; Pulmonary embolism; Thrombolytic therapy

Indexed keywords

DEXAMETHASONE; ENDOTHELIN 1; FIBRINOLYTIC AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANIMAL; ARTICLE; LUNG EMBOLISM; METABOLISM; PATHOLOGY; RABBIT;

ANIMALS; DEXAMETHASONE; ENDOTHELIN-1; FIBRINOLYTIC AGENTS; NF-KAPPA B; PULMONARY EMBOLISM; RABBITS;

EID: 33751093783     PISSN: 10010939     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Galie N, Manes A, Branzi A. The endothelin system in pulmonary arterial hypertension. Cardiovasc Res J, 2004, 61: 227-237.
2. Stelzner TJ, Yanagizawa T, Sakurai K, et al. Increase lung preproendothelin-mRNA expression in rats with pulmonary hypertension. FASEB J, 1998, 4: 1147-1156.
3. Ohkita M, Takaoka M, Shiota Y, et al. A nuclear factor-kappaB inhibitor BAY 11-7082 suppresses endothelin-1 production in cultured vascular endothelial cells. Jpn J Pharmacol, 2002, 89: 81-84.